Clinical Trial Update: A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of Propionyl-L-carnitine tablets for peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Propionyl-L-carnitine tablets (Propionyl-L-carnitine)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Peripheral Arterial Disease | Phase 3 | Status: COMPLETED